dulaglutide, NEJM, 2025 Semaglutide and cartilage regeneration Cell Metabolism, 2026 Lean mass loss with GLP-1 drugs systematic review, 2024 Retatrutide Phase 2 NEJM, 2023 Myostatin gene discovery McPherron et al., Nature, 1997 German myostatin-knockout child Schuelke et al., NEJM, 2004 Myostatin inhibitor history Nielsen et al., Cells, 2021 Micronutrient joint advisory Mozaffarian et al., 2025 Last Updated on June 20, 2026 by Joe Garma
While its not traditionally viewed as a fat-loss peptide, it plays a crucial supporting role in the blend: BPC-157 Benefits: Repairs gut lining (essential for metabolism and inflammation control) Accelerates tendon, ligament, and muscle recovery Enhances nitric oxide signaling (improves circulation and fat mobilization) Reduces systemic and local inflammation Supports insulin sensitivity through gut barrier restoration Chronic inflammation and leaky gut are major roadblocks in metabolic health
Those with severe obesity (BMI 35 kg/m), a group where significant body weight reductions have been observed in research settings
This personalized approach maximizes your results while protecting your long-term health and energy levels throughout your weight loss journey
Hakvoort, J
doi: 10.2337/diab.45.5.552
